Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP237846.RA92YeKqmcmjxyk2M4wzUZ2GDbqPNNC-igxtasL_GNu9o130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP237846.RA92YeKqmcmjxyk2M4wzUZ2GDbqPNNC-igxtasL_GNu9o130_assertion type Assertion NP237846.RA92YeKqmcmjxyk2M4wzUZ2GDbqPNNC-igxtasL_GNu9o130_head.
- NP237846.RA92YeKqmcmjxyk2M4wzUZ2GDbqPNNC-igxtasL_GNu9o130_assertion wasGeneratedBy ECO_0000203 NP237846.RA92YeKqmcmjxyk2M4wzUZ2GDbqPNNC-igxtasL_GNu9o130_provenance.
- NP237846.RA92YeKqmcmjxyk2M4wzUZ2GDbqPNNC-igxtasL_GNu9o130_assertion wasDerivedFrom befree-20140225 NP237846.RA92YeKqmcmjxyk2M4wzUZ2GDbqPNNC-igxtasL_GNu9o130_provenance.
- NP237846.RA92YeKqmcmjxyk2M4wzUZ2GDbqPNNC-igxtasL_GNu9o130_assertion SIO_000772 16621959 NP237846.RA92YeKqmcmjxyk2M4wzUZ2GDbqPNNC-igxtasL_GNu9o130_provenance.
- NP237846.RA92YeKqmcmjxyk2M4wzUZ2GDbqPNNC-igxtasL_GNu9o130_assertion evidence source_evidence_literature NP237846.RA92YeKqmcmjxyk2M4wzUZ2GDbqPNNC-igxtasL_GNu9o130_provenance.
- NP237846.RA92YeKqmcmjxyk2M4wzUZ2GDbqPNNC-igxtasL_GNu9o130_assertion description "[Elements of variation in the clinical course of CD38(+) CLL patients include (1) potential intersection with ZAP-70, a kinase involved in the CD38 signaling pathway in T and natural killer (NK) cells, and (2) the effects of genetic polymorphisms of the receptors involved, at least of CD38 and CD31.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP237846.RA92YeKqmcmjxyk2M4wzUZ2GDbqPNNC-igxtasL_GNu9o130_provenance.